Effectiveness of dry eye therapy under conditions of environmental stress

Current Eye Research

Volumn 38, Issue 2, 2013, Pages 229-236

  Tomlinson, Alan ^a   Madden, Louise C ^a   Simmons, Peter A ^b  

^a GLASGOW CALEDONIAN UNIVERSITY   (United Kingdom)

^b ALLERGAN INC   (United States)

Author keywords

Dry eye therapy; Environment; Humidity

Indexed keywords

CARMELLOSE SODIUM; EYE DROPS; GLYCEROL; LIPID; LUBRICATING AGENT; REFRESH TEAR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG FORMULATION; DRY EYE; ENVIRONMENTAL STRESS; EVAPORATION; FEMALE; HUMAN; MALE; OSMOLARITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SYMPTOM; TEAR FILM; TREATMENT DURATION;

EID: 84873899896     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.757323     Document Type: Article

References (39)

1. Lemp MA, Crews LA, Bron AJ, Foulks GN, Sullivan BD. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea 2012; 31(5):472-8.
2. Schlote T, Kadner G, Freudenthaler N. Marked reduction and distinct patterns of eye blinking in patients with moderately dry eyes during video display terminal use. Graefes Arch Clin Exp Ophthalmol 2004;242:306-312.
3. Backman H, Haghighat F. Indoor-air quality and ocular discomfort. J Am Optom Assoc 1999;70:309-316.
4. Abelson MB, Ousler 3rd GW, Nally LA, Welch D, Krenzer K. Alternative reference values for tear film break up time in normal and dry eye populations. Adv Exp Med Biol 2002;506:1121-1125.
5. Ousler 3rd GW, Abelson MB, Nally LA, Welch D, Casavant JS. Evaluation of the time to ";natural compensation"; in normal and dry eye subject populations during exposure to a controlled adverse environment. Adv Exp Med Biol 2002;506:1057-1063.
6. McCulley JP, Aronowicz JD, Uchiyama E, Shine WE, Butovich IA. Correlations in a change in aqueous tear evaporation with a change in relative humidity and the impact. Am J Ophthalmol 2006;141:758-760.
7. Uchiyama E, Aronowicz JD, Butovich IA, McCulley JP. Increased evaporative rates in laboratory testing conditions simulating airplane cabin relative humidity: an important factor for dry eye syndrome. Eye Contact Lens 2007;33:174-176.
8. Abelson MB, Ousler 3rd GW, Nally LA, Emory TB. Dry eye syndromes: diagnosis, clinical trials and pharmaceutical treatment-'improving clinical trials'. Adv Exp Med Biol 2002;506:1079-1086.
9. Abelson MB, Kaplan AP. A randomized, double-blind, placebo-controlled comparison of emedastine 0.05 ophthalmic solution with loratadine 10mg and their combination in the human conjunctival allergen challenge model. Clin Ther 2002;24:445-456.
10. González-García MJ, González-Sáiz A, de la Fuente B, Morilla-Grasa A, Mayo-Iscar A, San-José J, et al. Exposure to a controlled adverse environment impairs the ocular surface of subjects with minimally symptomatic dry eye. Invest Ophthalmol Vis Sci 2007;48:4026-4032.
11. Khanal S, Simmons PA, Pearce EI, Day M, Tomlinson A. Effect of artificial tears on tear stress test. Optom Vis Sci 2008;85:732-739.
12. Khanal S, Tomlinson A, Pearce EI, Simmons P. Effect of an oil in water emulsion on the tear physiology of patients with mild to moderate dry eye. Cornea 2007;26:175-181.
13. Korb DR, Scaffidi RC, Greiner JV, Kenyon KR, Herman JP, Blackie CA, et al. The effect of two novel lubricant eye drops on tear film lipid layer thickness in subjects with dry eye symptoms. Optom Vis Sci 2005;82:594-601.
14. Nepp J, Schauersberger J, Schild G, Jandrasits K, Haslinger-Akramian J, Derbolav A, et al. The clinical use of viscoelastic artificial tears and sodium chloride in dryeye syndrome. Biomaterials 2001;22:3305-3310.
15. Prabhasawat P, Tesavibul N, Kasetsuwan N. Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study. Br J Ophthalmol 2007;91:47-50.
16. McCann LC, Tomlinson A, Pearce EI, Papa V. Effectiveness of artificial tears in the management of evaporative dry eye. Cornea 2012;31(1):1-5.
17. Pearce EI, Tomlinson A, Blades KJ, Falkenberg HK, Lindsay B, Wilson CG. Effect of an oil and water emulsion on tear evaporation rate. Adv Exp Med Biol 2002;506:419-423.
18. Hirji N, Patel S, Callander M. Human tear film pre-rupture phase time (TP-RPT)- A non-invasive technique for evaluating the pre-corneal tear film using a novel keratometer mire. Ophthalmic Physiol Opt 1989;9:139-142.
19. Thai LC, Tomlinson A, Simmons PA. In vitro and in vivo effects of a lubricant in a contact lens solution. Ophthalmic Physiol Opt 2002;22:319-329.
20. Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 2000;118(5):615-21.
21. Madden LC, Tomlinson A, Simmons PA. Effect of Humidity Varations in a Controlled Environment Chamber on Human Tear Evaporation Rate Following Dry Eye Therapy. Eye and Contact Lens, in press.
22. Khanal S, Tomlinson A, Diaper CJ. Tear physiology of aqueous deficiency and evaporative dry eye. Optom Vis Sci 2009;86:1235-1240.
23. Tomlinson A, Doane MG, McFadyen A. Inputs and outputs of the lacrimal system: review of production and evaporative loss. Ocul Surf 2009;7:186-198.
24. Trees GR, Tomlinson A. Effect of artificial tear solutions and saline on tear film evaporation. Optom Vis Sci 1990;67:886-890.
25. Sullivan B. Clinical resorts of a first generation lab-on-chip nanolitre tear film osmometer. Ocul Surf 2005;3:S117.
26. Foulks GN. DEWS report. Ocular Surf 2007;5, in press.
27. Geerling G, Tauber J, Baudouin C, Goto E, Matsumoto Y, O'Brien T, et al. The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction. Invest Ophthalmol Vis Sci 2011;52(4):2050-2064.
28. Sullivan BD, Crews LA, Sönmez B, de la Paz MF, Comert E, Charoenrook V,et al. Clinical Utility of Objective Tests for Dry Eye Disease: Variability Over Time and Implications for Clinical Trials. Cornea 2012;31:1000-8.
29. Uchiyama E, Di Pascuale MA, Butovich IA, McCulley JP. Impact on ocular surface evaporation of an artificial tear solution containing hydroxypropyl guar. Eye Contact Lens 2008;34:331-334.
30. Khanal S, Tomlinson A, Pearce EI, Simmons PA. Effect of an oil-in-water emulsion on the tear physiology of patients with mild to moderate dry eye. Cornea 2007;26:175-181.
31. Grene RB, Lankston P, Mordaunt J, Harrold M, Gwon A, Jones R. Unpreserved carboxymethylcellulose artificial tears evaluated in patients with keratoconjunctivitis sicca. Cornea 1992;11:294-301.
32. Simmons PA, Vehige JG. Clinical performance of a midviscosity artificial tear for dry eye treatment. Cornea 2007;26:294-302.
33. Guillon M, Maissa C, Ho S. Evaluation of the effects on conjunctival tissues of Optive eyedrops over one month usage. Cont Lens Anterior Eye 2010;33(2):93-9.
34. Scaffidi RC, Korb DR. Comparison of the efficacy of two lipid emulsion eyedrops in increasing tear film lipid layer thickness. Eye Contact Lens 2007;33:38-44.
35. Korb DR, Greiner JV. Increase in tear film lipid layer thickness following treatment of meibomian gland dysfunction. Adv Exp Med Biol 1994;350:293-298.
36. Korb DR, Greiner JV, Glonek T, Whalen A, Hearn SL, Esway JE, et al. Human and rabbit lipid layer and interference pattern observations. Adv Exp Med Biol 1998;438:305-308.
37. Tiffany JM, Todd BS, Baker MR. Computer-assisted calculation of exposed area of the human eye. Adv Exp Med Biol 1998;438:433-439.
38. Nelson JD, Farris RL. Sodium hyaluronate and polyvinyl alcohol artificial tear preparations: a comparison in patients with keratoconjunctivitis sicca. Arch Ophthalmol 1988;106:484-487.
39. Simmons PA, Carlisle-Wilcox C, Beard B, Chen R, Liu H, Vehige JG, et al. Mechanism of lipid release and clinical performance of an advanced lipid-containing artificial tear formulation (E Abstract 2361). The association for research in vision and ophthalmology. Vol. 53, 6-10 May, Fort Lauderdale, FL: Invest Ophthalmol Vis Sci; 2012.